🇺🇸 FDA
Patent

US 11078170

Cyclic sulfamide compounds and methods of using same

granted A61PA61P31/12A61P31/20

Quick answer

US patent 11078170 (Cyclic sulfamide compounds and methods of using same) held by ASSEMBLY BIOSCIENCES, INC. expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ASSEMBLY BIOSCIENCES, INC.
Grant date
Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
35
CPC classes
A61P, A61P31/12, A61P31/20